Alert: New Earnings Report (2/27/24)-Cytokinetics Inc (NASDAQ: CYTK).
Cytokinetics Inc (NASDAQ: CYTK) has reported a loss for its fourth fiscal quarter (ending December 31) of $-1.38 versus a loss $-1.45 for the same period a year ago. This result fell short of the […]